Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Comparison of the Effects of SGLT-2i versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus based on Baseline Renal Function

Yu Wang, Chao Xia, Manna Li, Gaosi Xu

Diabetes db240688

https://doi.org/10.2337/db24-0688

Published: 11 February 2025

View articletitled, Comparison of the Effects of SGLT-2i versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus based on Baseline Renal Function

Journal Articles

Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts

Yaling Tang, Lynn Ang, Mamta Jaiswal, Brendan R. Dillon, Nazanene H. Esfandiari, Hetal S. Shah, Cathie Spino, Cindy Plunkett, Bruce A. Perkins, Rodica Pop-Busui, Alessandro Doria

Diabetes 2024;73(5):751–762

https://doi.org/10.2337/db23-0247

Published: 19 July 2023

View articletitled, Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts

Meeting Abstracts

418-P: Allometric Body Shape Indices, T2D, and Kidney Function—A Two-Sample Mendelian Randomization Study

ALISA D. KJAERGAARD, JESSE KRAKAUER, NIR KRAKAUER, ALEXANDER TEUMER, THOMAS W. WINKLER, CHRISTINA ELLERVIK

Diabetes 2023;72(Supplement_1):418-P

https://doi.org/10.2337/db23-418-P

Published: 20 June 2023

View articletitled, 418-P: Allometric Body Shape Indices, T2D, and Kidney Function—A Two-Sample Mendelian Randomization Study

Meeting Abstracts

416-P: Effect of Intensive Lifestyle Intervention on Renal Function in Patients with Diabetes and Obesity—A 10-Year Longitudinal Study

TAREQ SALAH, MARWA AL-BADRI, SHILTON E. DHAVER, ABDELRAHMAN KHATER, KARIM KIBAA, RYAN MCCARRAGHER, OSAMA HAMDY

Diabetes 2023;72(Supplement_1):416-P

https://doi.org/10.2337/db23-416-P

Published: 20 June 2023

View articletitled, 416-P: Effect of Intensive Lifestyle Intervention on Renal Function in Patients with Diabetes and Obesity—A 10-Year Longitudinal Study

Meeting Abstracts

413-P: Intensive Insulin Therapy Delays the “Breakpoint” to Progressive Kidney Function Decline—New Findings and Implications of eGFR Trajectory Analysis in DCCT/EDIC Data

KATSUHITO IHARA, JAN K. SKUPIEN, EIICHIRO SATAKE, BRUCE A. PERKINS, ANDRZEJ KROLEWSKI

Diabetes 2023;72(Supplement_1):413-P

https://doi.org/10.2337/db23-413-P

Published: 20 June 2023

View articletitled, 413-P: Intensive Insulin Therapy Delays the “Breakpoint” to Progressive Kidney Function Decline—New Findings and Implications of eGFR Trajectory Analysis in DCCT/EDIC Data

Meeting Abstracts

1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

ARJOLA BANO, CARLOS BUENO, JUNIOR, YALING TANG, XIUQIN SUN, ELIZABETH HALL, JOANNA MITRI, MARIO LUCA MORIERI, HETAL SHAH, ALESSANDRO DORIA

Diabetes 2023;72(Supplement_1):1226-P

https://doi.org/10.2337/db23-1226-P

Published: 20 June 2023

View articletitled, 1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

Meeting Abstracts

428-P: Diabetic Retinopathy Predicts Hemodialysis Induction in Subjects with Type 2 Diabetes with Normo- and Microalbuminuria and Normal Renal Function

TATSUMI MORIYA, AKIHIKO SUZUKI, AKINORI HAYASHI, MADOKA MATSUBARA, TAKESHI MIYATSUKA

Diabetes 2023;72(Supplement_1):428-P

https://doi.org/10.2337/db23-428-P

Published: 20 June 2023

View articletitled, 428-P: Diabetic Retinopathy Predicts Hemodialysis Induction in Subjects with Type 2 Diabetes with Normo- and Microalbuminuria and Normal Renal Function

Meeting Abstracts

238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years

ALICE L.J. CARR, BRAULIO A. MARFIL-GARZA, YING LING, RICHARD A. ORAM, ANNA LAM, BLAIRE L. ANDERSON, DOUG O'GORMAN, TATSUYA KIN, DAVID BIGAM, A.M. JAMES SHAPIRO, PETER A. SENIOR

Diabetes 2023;72(Supplement_1):238-OR

https://doi.org/10.2337/db23-238-OR

Published: 20 June 2023

View articletitled, 238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years

Meeting Abstracts

1309-P: Dietary Iron and Kidney Function in Youth and Young Adults with Type 1 Diabetes

REBECCA B. CONWAY, TESSA L. CRUME, WEI PERNG, DONALD A. MCCLAIN, DANA DABELEA

Diabetes 2023;72(Supplement_1):1309-P

https://doi.org/10.2337/db23-1309-P

Published: 20 June 2023

View articletitled, 1309-P: Dietary Iron and Kidney Function in Youth and Young Adults with Type 1 Diabetes

Meeting Abstracts

427-P: Comparison of Diabetic Kidney Disease Risk Factors between Normoalbuminuric Reduced and Albuminuric Preserved Kidney Function Groups

MITRA MOSSLEMI, TINA COSTACOU

Diabetes 2023;72(Supplement_1):427-P

https://doi.org/10.2337/db23-427-P

Published: 20 June 2023

View articletitled, 427-P: Comparison of Diabetic Kidney Disease Risk Factors between Normoalbuminuric Reduced and Albuminuric Preserved Kidney Function Groups

Meeting Abstracts

808-P: Pharmacokinetic Properties of Once-Weekly Insulin Icodec in Individuals with Renal Impairment vs. Normal Renal Function

HANNE HAAHR, NIELS R. KRISTENSEN, JONAS H. LARSEN, FRANK-DIETRICH H. WAGNER, STANISLAV IGNATENKO

Diabetes 2023;72(Supplement_1):808-P

https://doi.org/10.2337/db23-808-P

Published: 20 June 2023

View articletitled, 808-P: Pharmacokinetic Properties of Once-Weekly Insulin Icodec in Individuals with Renal Impairment vs. Normal Renal Function

Meeting Abstracts

10-OR: The Triple Roles of Tubular Mitochondria AKT in the Regulation of Renal Function, Insulin Resistance, and Body Composition during Development of Diabetic Nephropathy

ESAM SALEM, ALBERT TA, HUGO Y.H. LIN, JUNFENG LI, PING H. WANG

Diabetes 2023;72(Supplement_1):10-OR

https://doi.org/10.2337/db23-10-OR

Published: 20 June 2023

View articletitled, 10-OR: The Triple Roles of Tubular Mitochondria AKT in the Regulation of Renal Function, Insulin Resistance, and Body Composition during Development of Diabetic Nephropathy

Meeting Abstracts

874-P: Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes—A Real-World Study

AMIR BASHKIN, ETTY KRUZEL-DAVILA, ITAI TZFONI

Diabetes 2023;72(Supplement_1):874-P

https://doi.org/10.2337/db23-874-P

Published: 20 June 2023

View articletitled, 874-P: Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes—A Real-World Study

Meeting Abstracts

867-P: Favorable Kidney Outcomes Are Associated with Empagliflozin vs. DPP4i in Patients with Diabetes and Normal Kidney Function Real-World Evidence

MEIR SCHECHTER, CHELI MELZER COHEN, ALIZA ROZENBERG, ILAN YANUV, GABRIEL CHODICK, OFRI MOSENZON, AVRAHAM KARASIK

Diabetes 2022;71(Supplement_1):867-P

https://doi.org/10.2337/db22-867-P

Published: 01 June 2022

View articletitled, 867-P: Favorable Kidney Outcomes Are Associated with Empagliflozin vs. DPP4i in Patients with Diabetes and Normal Kidney Function Real-World Evidence

Meeting Abstracts

405-P: Glycemic Control Impacts Renal Function Decline among People with Type 1 Diabetes after the Onset of Diabetic Kidney Disease

HETAL SHAH, JANET B. MCGILL, IRL B. HIRSCH, CHUN-YI WU, ANDRZEJ GALECKI, MICHAEL MAUER, ALESSANDRO DORIA, PERL CONSORTIUM

Diabetes 2022;71(Supplement_1):405-P

https://doi.org/10.2337/db22-405-P

Published: 01 June 2022

View articletitled, 405-P: Glycemic Control Impacts Renal Function Decline among People with Type 1 Diabetes after the Onset of Diabetic Kidney Disease

Meeting Abstracts

1477-PUB: The Comparison between Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonist Treatment Depending on the Change in Blood Pressure in Japanese Patients with Type 2 Diabetes Mellitus on the Renal Function

KAZUO KOBAYASHI, MASAO TOYODA, NOBUO HATORI, KOUICHI TAMURA

Diabetes 2022;71(Supplement_1):1477-PUB

https://doi.org/10.2337/db22-1477-PUB

Published: 01 June 2022

View articletitled, 1477-PUB: The Comparison between Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonist Treatment Depending on the Change in Blood Pressure in Japanese Patients with Type 2 Diabetes Mellitus on the Renal Function

Meeting Abstracts

855-P: PromarkerD Predicts Late-Stage Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

KIRSTEN E. PETERS, PATSY DI PRINZIO, SCOTT BRINGANS, WENDY A. DAVIS, TIMOTHY DAVIS, RICHARD J. LIPSCOMBE, MICHAEL K. HANSEN

Diabetes 2022;71(Supplement_1):855-P

https://doi.org/10.2337/db22-855-P

Published: 01 June 2022

View articletitled, 855-P: PromarkerD Predicts Late-Stage Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

Meeting Abstracts

963-P: Preservation of Renal Function in Patients with Diabetes and Comorbid CKD 3 as Measured by eGFR in 1,877 Elderly Patients at CanoHealth. A Two-Year Retrospective EHR-Based Analysis.

RICHARD AGUILAR, ROBERT E. KENNEY, EFRAIN ANTUNEZ, MERLIN OSORIO, MARY HERMAN, MORGAN CONGER, MICHELLE AGUILAR

Diabetes 2022;71(Supplement_1):963-P

https://doi.org/10.2337/db22-963-P

Published: 01 June 2022

View articletitled, 963-P: Preservation of Renal Function in Patients with Diabetes and Comorbid CKD 3 as Measured by eGFR in 1,877 Elderly Patients at CanoHealth. A Two-Year Retrospective EHR-Based Analysis.

Meeting Abstracts

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

PHILIP HOME, JULIO ROSENSTOCK, FRANCESCO GIORGINO, MATTHIAS BLÜHER, KHIER DJABALLAH, KATRIN PEGELOW, LYDIE MELAS-MELT, RORY J. MCCRIMMON

Diabetes 2022;71(Supplement_1):846-P

https://doi.org/10.2337/db22-846-P

Published: 01 June 2022

View articletitled, 846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

Meeting Abstracts

1177-P: Mediterranean Diet Is Associated with a Better Estimated Renal Function in Overweight, but Not in Obese, Adults with Impaired Fasting Glucose

ALESSANDRO LEONE, RAMONA DE AMICIS, ANDREA FOPPIANI, SIMONA BERTOLI, ALBERTO BATTEZZATI

Diabetes 2022;71(Supplement_1):1177-P

https://doi.org/10.2337/db22-1177-P

Published: 01 June 2022

View articletitled, 1177-P: Mediterranean Diet Is Associated with a Better Estimated Renal Function in Overweight, but Not in Obese, Adults with Impaired Fasting Glucose

Update search

NARROW

Format

Journal

Article Type

Topics

Subjects

Issue Section

Date

Availability

Comparison of the Effects of SGLT-2i versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus based on Baseline Renal Function

Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts

418-P: Allometric Body Shape Indices, T2D, and Kidney Function—A Two-Sample Mendelian Randomization Study

416-P: Effect of Intensive Lifestyle Intervention on Renal Function in Patients with Diabetes and Obesity—A 10-Year Longitudinal Study

413-P: Intensive Insulin Therapy Delays the “Breakpoint” to Progressive Kidney Function Decline—New Findings and Implications of eGFR Trajectory Analysis in DCCT/EDIC Data

1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

428-P: Diabetic Retinopathy Predicts Hemodialysis Induction in Subjects with Type 2 Diabetes with Normo- and Microalbuminuria and Normal Renal Function

238-OR: Changes In Renal Function after Islet Transplantation in a Single-Centre Cohort in Canada over 20 Years

1309-P: Dietary Iron and Kidney Function in Youth and Young Adults with Type 1 Diabetes

427-P: Comparison of Diabetic Kidney Disease Risk Factors between Normoalbuminuric Reduced and Albuminuric Preserved Kidney Function Groups

808-P: Pharmacokinetic Properties of Once-Weekly Insulin Icodec in Individuals with Renal Impairment vs. Normal Renal Function

10-OR: The Triple Roles of Tubular Mitochondria AKT in the Regulation of Renal Function, Insulin Resistance, and Body Composition during Development of Diabetic Nephropathy

874-P: Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes—A Real-World Study

867-P: Favorable Kidney Outcomes Are Associated with Empagliflozin vs. DPP4i in Patients with Diabetes and Normal Kidney Function Real-World Evidence

405-P: Glycemic Control Impacts Renal Function Decline among People with Type 1 Diabetes after the Onset of Diabetic Kidney Disease

1477-PUB: The Comparison between Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide 1 Receptor Agonist Treatment Depending on the Change in Blood Pressure in Japanese Patients with Type 2 Diabetes Mellitus on the Renal Function

855-P: PromarkerD Predicts Late-Stage Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

963-P: Preservation of Renal Function in Patients with Diabetes and Comorbid CKD 3 as Measured by eGFR in 1,877 Elderly Patients at CanoHealth. A Two-Year Retrospective EHR-Based Analysis.

846-P: Advancing Therapy in Basal Insulin–Treated Type 2 Diabetes: Exploratory Analysis of the SoliMix Trial by Baseline Age, Diabetes Duration, and Renal Function

1177-P: Mediterranean Diet Is Associated with a Better Estimated Renal Function in Overweight, but Not in Obese, Adults with Impaired Fasting Glucose

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only